R. 1. Blum, J. Buffet, P. Visser, L. Harms, G. Bailey et al., LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014, Journal of Travel Medicine, vol.21, issue.2, pp.116-145, 2014.
DOI : 10.1007/s15010-013-0500-5

P. Buffet, E. ´. Rosenthal, J. Gangneux, E. Lightburne, P. Couppié et al., Traitement des leishmanioses en France??: proposition d???un r??f??rentiel consensuel, La Presse M??dicale, vol.40, issue.2, pp.173-84, 2011.
DOI : 10.1016/j.lpm.2010.09.023

M. Bailey and D. Lockwood, Cutaneous leishmaniasis, Clinics in Dermatology, vol.25, issue.2, pp.203-214, 2007.
DOI : 10.1016/j.clindermatol.2006.05.008

N. Aronson, B. Herwaldt, M. Libman, R. Pearson, R. Lopez-velez et al., Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the, Clin. Infect. Dis, vol.670, 2016.

S. Sundar, M. Rai, J. Chakravarty, D. Agarwal, N. Agrawal et al., New Treatment Approach in Indian Visceral Leishmaniasis: Single???Dose Liposomal Amphotericin B Followed by Short???Course Oral Miltefosine, Clinical Infectious Diseases, vol.83, issue.8, pp.1000-1006, 2008.
DOI : 10.1086/380971

A. Cascio, L. Di-martino, P. Occorsio, R. Giacchino, S. Catania et al., A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience, Journal of Antimicrobial Chemotherapy, vol.54, issue.1, pp.217-237, 2004.
DOI : 10.1093/jac/dkh279

R. Davidson, L. Di-martino, L. Gradoni, R. Giacchino, G. Gaeta et al., Short-Course Treatment of Visceral Leishmaniasis with Liposomal Amphotericin B (AmBisome), Clinical Infectious Diseases, vol.22, issue.6, pp.938-981, 1996.
DOI : 10.1093/clinids/22.6.938

M. Solomon, F. Pavlotsky, E. Leshem, M. Ephros, H. Trau et al., Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica, Journal of the European Academy of Dermatology and Venereology, vol.362, issue.2 Pt 1, pp.973-980, 2011.
DOI : 10.1056/NEJMoa0903627

G. Wortmann, M. Zapor, R. Ressner, S. Fraser, J. Hartzell et al., Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis, The American Journal of Tropical Medicine and Hygiene, vol.83, issue.5, pp.1028-1061, 2010.
DOI : 10.4269/ajtmh.2010.10-0171

C. Rocio, V. Amato, R. Camargo, F. Tuon, and A. Nicodemo, Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.48, issue.10, pp.176-184, 2014.
DOI : 10.1111/j.1365-4632.2009.04099.x

M. Solomon, E. Schwartz, F. Pavlotsky, N. Sakka, A. Barzilai et al., Leishmania tropica in children: A retrospective study, Journal of the American Academy of Dermatology, vol.71, issue.2, pp.271-278, 2014.
DOI : 10.1016/j.jaad.2013.12.047

G. Morizot, E. Kendjo, O. Mouri, M. Thellier, A. Perignon et al., Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy, Clinical Infectious Diseases, vol.368, issue.3, pp.370-80, 2013.
DOI : 10.1056/NEJMoa1202657
URL : https://hal.archives-ouvertes.fr/hal-00874622

J. Blum, LeishMan: harmonising diagnostic and clinical management of leishmaniasis in Europe, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull, vol.18, p.20538, 2013.

O. Mouri, G. Morizot, G. Auwera, . Der, C. Ravel et al., Easy Identification of Leishmania Species by Mass Spectrometry, PLoS Neglected Tropical Diseases, vol.107, issue.Pt 4, pp.2841-24902030, 2014.
DOI : 10.1371/journal.pntd.0002841.s007
URL : https://hal.archives-ouvertes.fr/hal-01343078

P. Olliaro, M. Vaillant, B. Arana, M. Grogl, F. Modabber et al., Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis, PLoS Neglected Tropical Diseases, vol.11, issue.3, p.23556016, 2013.
DOI : 10.1371/journal.pntd.0002130.t006
URL : https://hal.archives-ouvertes.fr/hal-01613478

R. Fielding, P. Smith, L. Wang, J. Porter, and L. Guo, Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats., Antimicrobial Agents and Chemotherapy, vol.35, issue.6, pp.1208-1221, 1991.
DOI : 10.1128/AAC.35.6.1208

T. Walsh, V. Yeldandi, M. Mcevoy, C. Gonzalez, S. Chanock et al., Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients, Antimicrob. Agents Chemother, vol.42, pp.2391-2399, 1998.

N. Stone, T. Bicanic, R. Salim, and W. Hope, AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions, Liposomal Amphotericin B Drugs, vol.76, pp.485-500, 2016.

A. Salah, A. Zaâtour, N. Messaoud, A. Kidar, P. Smith et al., Parasite Load Decrease during Application of a Safe and Easily Applied Antileishmanial Aminoglycoside Cream, PLoS Neglected Tropical Diseases, vol.32, issue.5, pp.2749-24853096, 2014.
DOI : 10.1371/journal.pntd.0002749.s002
URL : https://hal.archives-ouvertes.fr/hal-01358522

G. Morizot, R. Jouffroy, F. A. Chabert, P. Belhouari, K. Calin et al., Antimony to Cure Visceral Leishmaniasis Unresponsive to, Liposomal Amphotericin B. PLoS Negl. Trop. Dis, vol.10, p.26735920, 2016.
DOI : 10.1371/journal.pntd.0004304
URL : https://hal.archives-ouvertes.fr/hal-01306782

M. Mirzabeigi, U. Farooq, S. Baraniak, L. Dowdy, G. Ciancio et al., Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient, Journal of Cutaneous Pathology, vol.97, issue.10, pp.701-705, 2006.
DOI : 10.1590/S0074-02762002000900002

E. Khalil, T. Weldegebreal, B. Younis, R. Omollo, A. Musa et al., Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome?? for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial, PLoS Neglected Tropical Diseases, vol.12, issue.1, pp.2613-24454970, 2014.
DOI : 10.1371/journal.pntd.0002613.s002

H. Taquin, C. Chiaverini, P. Marty, and J. Lacour, Une forme profuse de leishmaniose cutan??e ?? Leishmania infantum chez une enfant immunocomp??tente, trait??e par amphot??ricine B liposomale en cure courte, Annales de Dermatologie et de V??n??r??ologie, vol.143, issue.10, pp.622-626, 2016.
DOI : 10.1016/j.annder.2016.03.025

T. Del-rosal, F. Artigao, M. Miguel, R. De-lucas, and F. Del-castillo, Successful Treatment of Childhood Cutaneous Leishmaniasis with Liposomal Amphotericin B: Report of Two Cases, Journal of Tropical Pediatrics, vol.56, issue.4, pp.122-126, 2010.
DOI : 10.1016/j.jaad.2006.06.044

L. Neves, A. Talhari, E. Gadelha, S. Júnior, R. Da et al., Estudo cl??nico randomizado comparando antimoniato de meglumina, pentamidina e anfotericina B para o tratamento da leishmaniose cut??nea ocasionada por Leishmania guyanensis, Anais Brasileiros de Dermatologia, vol.41, issue.6, pp.1092-101, 2011.
DOI : 10.1111/j.1365-4632.2009.03883.x
URL : http://www.scielo.br/pdf/abd/v86n6/en_v86n6a05.pdf

J. Motta and R. Sampaio, A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis, Journal of the European Academy of Dermatology and Venereology, vol.33, issue.3, pp.331-336, 2012.
DOI : 10.1590/S0037-86822000000600004

M. Solomon, F. Pavlotzky, A. Barzilai, and E. Schwartz, Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers, Journal of the American Academy of Dermatology, vol.68, issue.2, pp.284-293, 2013.
DOI : 10.1016/j.jaad.2012.06.014

M. Solomon, S. Baum, A. Barzilai, A. Scope, H. Trau et al., Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis, Journal of the American Academy of Dermatology, vol.56, issue.4, pp.612-618, 2007.
DOI : 10.1016/j.jaad.2006.06.044

G. Harms, H. Scherbaum, I. Reiter-owona, A. Stich, and J. Richter, Treatment of imported New World cutaneous leishmaniasis in Germany, International Journal of Dermatology, vol.100, issue.Suppl, pp.1336-1378, 2011.
DOI : 10.1016/j.trstmh.2005.03.012

P. Machado, M. Rosa, L. Guimarães, F. Prates, A. Queiroz et al., Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B, Clinical Infectious Diseases, vol.71, issue.6, pp.945-954, 2015.
DOI : 10.1016/j.jaad.2012.06.014

V. Mosimann, C. Blazek, H. Grob, M. Chaney, A. Neumayr et al., Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature: Table 1., Open Forum Infectious Diseases, vol.31, issue.1, pp.8-27042675, 2016.
DOI : 10.1016/j.tmaid.2013.05.003

R. Silva, . Da, A. Toledo, M. Senna, A. Rabello et al., Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre, Mem??rias do Instituto Oswaldo Cruz, vol.87, issue.2, pp.512-518, 2016.
DOI : 10.4269/ajtmh.2012.11-0612

A. Salah, P. Buffet, G. Morizot, N. Massoud, A. Zâatour et al., WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study, PLoS Neglected Tropical Diseases, vol.13, issue.5, p.432, 2009.
DOI : 10.1371/journal.pntd.0000432.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00859427

B. Salah, A. , B. Messaoud, N. Guedri, E. Zaatour et al., Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis, New England Journal of Medicine, vol.368, issue.6, pp.524-556, 2013.
DOI : 10.1056/NEJMoa1202657
URL : https://hal.archives-ouvertes.fr/pasteur-00793585